FARALLON CAPITAL MANAGEMENT LLC – United Therapeutics Corporation Transaction History
FARALLON CAPITAL MANAGEMENT LLC portfolio value:
$115.09M
portfolio value
FARALLON CAPITAL MANAGEMENT LLC quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +39.97% | 156.97K shares | 22.55M | $209.38 | 549.67K |
| Q2 2022 | share | Increase | +3.42% | 13K shares | 24.41M | $235.64 | 392.69K |
| Q1 2022 | share | Increase | +18.37% | 58.93K shares | -1.18M | $179.41 | 379.69K |
| Q4 2021 | share | Increase | 0.00% | 320.76K shares | 69.31M | $215.18 | 320.76K |
| Q3 2020 | share | Decrease | -100.00% | -350K shares | -42.35M | $101 | 0 |
| Q2 2020 | share | Decrease | -4.11% | -15K shares | 7.73M | $121 | 350K |
| Q1 2020 | share | Increase | 0.00% | 365K shares | 34.61M | $94.83 | 365K |